info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » therapeutics

therapeutics

Herpes Labialis Treatment Market By Treatment Type (Oral Antivirals, Topical Antivirals, OTC Products, Vaccines); By End-User (Consumers, Healthcare Providers, Retail Pharmacies, Online Pharmacies); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Herpes Labialis Treatment Market was valued at USD 4.5 billion in 2024, and is projected to grow at a CAGR of 6.4%, reac... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Neurotrophic Keratitis Treatment Market By Therapy Type (Prescription Growth Factor Therapy, Peptide and Pipeline Therapies, Supportive Ocular Surface Therapies, Surgical and Procedural Interventions), By Disease Stage (Stage 1, Stage 2, Stage 3), By End User (Hospitals, Specialty Eye Clinics, Cornea Treatment Centers, Ambulatory Surgical Centers), By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Neurotrophic Keratitis Treatment Market Gains Value from Orphan Drug Access, Corneal-Healing Evidence, and Pipeline Pressure on Oxervate

The Global Neurotrophic Keratitis Treatment Market was valued at USD 826 million in 2025 and is projected to reach USD 1.40 billion... Read More

Published Date: JUL-2026 | No Of Pages:188 | $ 4485

Necrotising Enterocolitis Market By Product Type (Pharmaceutical Interventions, Nutritional Therapies, Diagnostic Tools, Surgical Equipment); By End User (Neonatal Intensive Care Units, Pediatric & Maternity Hospitals, Research Institutes); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Necrotising Enterocolitis ( NEC ) Market is projected to grow at a CAGR of 6.8%, increasing from an estimated USD 460 million in 2024 to ... Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Palmoplantar Keratoderma Market By Type (Hereditary PPK, Acquired PPK); By Treatment (Topical Therapies, Systemic Therapies, Gene & Molecular Therapies); By End User (Specialty Dermatology Clinics, General Dermatology Practices, Retail & Online Pharmacies, Teledermatology Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Palmoplantar Keratoderma ( PPK ) Market is projected to grow steadily over the next several years, reaching a valuation of $1.04 billion by 2030, up from ... Read More

Published Date: JAN-2026 | No Of Pages:164 | $ 4485

Retinitis Pigmentosa Market By Treatment Type (Gene Therapy, Stem Cell Therapy, Optogenetics & Prosthetics, Adjunct Therapies); By Route of Administration (Intraocular, Oral/Systemic, Sustained-Release Ocular Implants); By End User (Specialized Ophthalmology Centers, Academic Hospitals, General Hospitals, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Retinitis Pigmentosa Market growing at 5.8% CAGR, with USD 560 million in 2024 to USD 785 million by 2030, driven by retinitis pigmentosa treatmen... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Pyoderma Gangrenosum Treatment Market By Treatment Type (Topical Treatments, Systemic Treatments, Surgical Treatments); By End User (Hospitals, Dermatology Clinics, Outpatient Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pyoderma Gangrenosum Treatment Market will witness steady growth from USD 1.2 billion in 2024 to USD 2.3 billion by 2030 at a CAGR of 10.6%, supported by ... Read More

Published Date: JAN-2026 | No Of Pages:153 | $ 4485

Pediatric Brain Tumor Market By Imaging Modality (MRI, CT, Ultrasound, Functional MRI, Low-Dose CT); By Tumor Type (Gliomas, Medulloblastomas, Neuroblastomas, Others); By End-User (Children’s Hospitals, General Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pediatric Brain Tumor Market is driven by expanding pediatric oncology diagnostics, brain tumor screening technologies, neuroimaging diagnostics, ... Read More

Published Date: JAN-2026 | No Of Pages:191 | $ 4485

Optic Neuritis Treatment Market By Treatment Type (Corticosteroids, Immunomodulators & Disease-Modifying Therapies, Monoclonal Antibodies, Plasma Exchange & Others); By Indication (MS-Associated Optic Neuritis, NMOSD, Infectious & Other Autoimmune Causes); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Specialty & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Optic Neuritis Treatment Market is witnessing growth at CAGR of 8.1%, expanding from USD 1.7 billion in 2024 to USD 2.9 billion by 2030, propelled by Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Multiple System Atrophy Market By Treatment Type (Symptomatic Therapies, Disease-Modifying Pipeline, Supportive Devices); By Diagnosis (Imaging, Fluid Biomarkers, Clinical Assessment); By End User (Hospitals, Neurology Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Multiple System Atrophy Market is forecast to register a CAGR of 8.6%, valued at USD 380 million in 2024 and reaching USD 625 million by 2030, driven by <... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Refractory Epilepsy Treatment Market By Treatment Type (Anti-Epileptic Drugs, Vagus Nerve Stimulation, Responsive Neurostimulation, Deep Brain Stimulation, Surgical Resection, Dietary Therapies); By Route of Administration (Oral, Injectable, Implanted Devices); By End User (Hospitals, Neurology Clinics, Pediatric Epilepsy Centers, Ambulatory Surgery Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Refractory Epilepsy Treatment Market is projected to grow at a robust CAGR of 6.9%, valued at USD 6.7 billion in 2024 and expected to surpass USD 10.1 billion by 2... Read More

Published Date: JAN-2026 | No Of Pages:177 | $ 4485

Post Bariatric Hypoglycemia Market By Treatment Type (Pharmacologic, Nutritional, Surgical Revision, Device-Assisted Monitoring); By Patient Profile (Early Onset PBH, Late Onset PBH, Refractory PBH, Asymptomatic PBH); By End User (Bariatric Surgery Centers, Endocrinology Clinics, Digital Therapeutics Platforms, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Post Bariatric Hypoglycemia Market valued at USD 1.1 billion in 2024 and expected to reach USD 1.6 billion by 2030 at CAGR of 6.8%, propelled by h... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Hyperuricemia Market By Drug Class (Xanthine Oxidase Inhibitors, Uricosuric / URAT1 Inhibitors, Uricase-Based Biologics, Anti-Inflammatory Gout Flare Therapies, Combination Therapies); By Clinical Type (Asymptomatic Hyperuricemia, Gout-Associated Symptomatic Hyperuricemia, Refractory / Uncontrolled Gout, Tumor Lysis Syndrome-Associated Hyperuricemia, Uric Acid Stone and Kidney-Associated Hyperuricemia); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Online Channels); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Hyperuricemia Market: Treatment Gaps and Next-Generation Urate Control Expand a Broad Metabolic Disease Category

The Global Hyperuricemia Market is valued at USD 5.65 billion in 2025 and is projected to reach USD 10.14 billion by 2032, registering a CAGR of 8.7%, acco... Read More

Published Date: JUL-2026 | No Of Pages:155 | $ 4485

Inflammatory Myopathy Market By Type (Polymyositis, Dermatomyositis, Inclusion Body Myositis, Necrotizing Autoimmune Myopathy, Others); By Treatment (Corticosteroids, Immunosuppressants, Intravenous Immunoglobulin (IVIG), Biologics, Others); By Route of Administration (Oral, Intravenous, Subcutaneous); By End User (Hospitals, Specialty Clinics, Home Infusion Providers, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Inflammatory Myopathy Market valued at USD 1.65 billion in 2024 and projected to reach USD 2.4 billion by 2030 at 6.4% CAGR, reflecting market gro... Read More

Published Date: JAN-2026 | No Of Pages:193 | $ 4485

Refractory Angina Treatment Market By Treatment Type (EECP, Coronary Sinus Reducers, Spinal Cord Stimulation, Transmyocardial Laser Revascularization, Cell & Gene Therapy, Pharmacologic Agents); By Mechanism of Action (Neuromodulation, Vascular Modulation, Hemodynamic Therapy, Regenerative Therapy, Metabolic Modulation); By End User (Tertiary Care Hospitals, Cardiology Specialty Clinics, Pain Management Centers, Outpatient Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Refractory Angina Treatment Market will witness a steady CAGR of 6.2%, valued at USD 1.6 billion in 2024 and projected to reach USD 2.3 billion by 2030, a... Read More

Published Date: JAN-2026 | No Of Pages:162 | $ 4485

Pertussis Treatment Market By Treatment Type (Macrolides, Sulfonamides, Combination Therapies, Vaccines); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospitals, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pertussis Treatment Market is projected to grow from USD 3.2 billion in 2024 to USD 4.9 billion by 2030 at a 7.3% CAGR, driven by rising vaccination programs, antibiotic therapies, and ped... Read More

Published Date: JAN-2026 | No Of Pages:155 | $ 4485

Paraganglioma Treatment Market by Treatment Type (Surgical Treatment, Radiotherapy, Pharmacological Treatment); By End-User (Hospitals, Diagnostic Imaging Centers, Research Institutes, Ambulatory Surgical Centers); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Paraganglioma Treatment Market valued at USD 1.2 billion in 2024 and forecast to reach USD 1.8 billion by 2030 at 5.3% CAGR, fueled by therapeutic... Read More

Published Date: JAN-2026 | No Of Pages:172 | $ 4485

Tonic-Clonic Seizure Market By Drug Class (Traditional AEDs, New-generation AEDs); By Route of Administration (Oral, Intravenous, Intranasal, Rectal); By Age Group (Pediatric, Adult, Geriatric); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tonic- Clonic Seizure Market will witness growth at CAGR of 5.8%, climbing from USD 1.87 billion in 2024 to USD 2.62 billion by 2030, supported by Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Transverse Myelitis Market By Treatment Approach (Corticosteroids, Plasma Exchange, IVIG, Immunosuppressants, Biologics); By Route of Administration (Intravenous, Oral, Subcutaneous); By End User (Hospitals, Specialty Clinics, Home Care, Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Transverse Myelitis Market will witness a robust CAGR of 6.5%, valued at $654 million in 2024, expected to appreciate and reach $961 million by 2030, acco... Read More

Published Date: JAN-2026 | No Of Pages:152 | $ 4485

Propionic Acidemia Market By Treatment Type (Medical Nutrition and Dietary Management, L-Carnitine Therapy, Antibiotic Therapy, Hyperammonemia Management, Acute Metabolic Crisis Stabilization, Liver Transplantation, Emerging mRNA Therapy); By Diagnostic Approach (Newborn Screening, Biochemical Testing, Molecular Genetic Testing, Enzyme-Activity Testing); By Age Group (Neonates and Infants, Children, Adolescents, Adults); By End User (Specialist Metabolic Centers, Hospitals and Emergency Departments, Diagnostic Laboratories, Transplant Centers, Research and Clinical-Trial Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Propionic Acidemia Market: Crisis Prevention and mRNA Therapy Redefine an Ultra-Rare Care Model An Ultra-Rare Market Built Around Avoiding High-Cost Metabolic Crises

The Global Propionic Acidemia Market was valued at USD 0.62 billion in 2025 and is projected to reach ... Read More

Published Date: Aug-2026 | No Of Pages:179 | $ 4485

Pheochromocytoma Treatment Market By Treatment Type (Surgical Resection, Systemic Therapy, Pre-operative Stabilization, Genetic Surveillance); By Drug Class (Alpha Blockers, Beta Blockers, Tyrosine Kinase Inhibitors, Radiopharmaceuticals, Chemotherapy); By End User (Tertiary Hospitals, Oncology Centers, Endocrinology Clinics, Nuclear Medicine Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pheochromocytoma Treatment Market is projected to reach USD 1.12 billion by 2030, growing from an estimated USD 750 million in 2024, reflecting a steady CAGRRead More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Hypophosphatasia Treatment Market By Therapy Type (Enzyme Replacement Therapy, Gene Therapy, Small Molecule Enzyme Activators, Supportive Therapies); By Route of Administration (Intravenous, Subcutaneous, Oral); By Patient Population (Perinatal & Infantile, Childhood, Adult); By Distribution Channel (Hospital Pharmacies, Specialty Distributors, Home Infusion Services); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hypophosphatasia Treatment Market is projected to grow at a robust CAGR of 10.6%, valued at USD 620.0 million in 2024, a... Read More

Published Date: JAN-2026 | No Of Pages:172 | $ 4485

Ischemic Stroke Market By Treatment Type (Thrombolytics, Mechanical Thrombectomy Devices, Antiplatelet Drugs, Anticoagulants, Others); By Diagnosis Modality (CT, MRI, Biomarkers, Others); By End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ischemic Stroke Market is set to expand at a consistent CAGR of around 6.8%, increasing from nearly $12.6 billion in 2024 to $18.7 billion by 2030, fueled... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Pediatric Growth Hormone Deficiency Market by Treatment Type (Recombinant Human Growth Hormone [rhGH], Growth Hormone Secretagogues, Gene Therapy); By Age Group (Children 0-12 Years, Adolescents 13-18 Years); By Mode of Administration (Subcutaneous Injections, Long-acting Growth Hormones, Non-injection Methods [Intranasal, Oral]); By End-User (Pediatric Hospitals, General Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers [ASCs]); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pediatric Growth Hormone Deficiency Market will record CAGR of 7.2% from 2024 to 2030, rising from USD 3.2 billion in 2024 to USD 5.4 billion by 2030, dri... Read More

Published Date: JAN-2026 | No Of Pages:154 | $ 4485

AL Amyloidosis Therapeutics Market By Product Type (Monoclonal Antibodies, Proteasome Inhibitors, Chemotherapy Agents, Immunomodulatory Drugs, Novel Targeted Therapies); By Treatment Modality (Combination Therapy, Monotherapy, Stem Cell Transplantation Supportive Therapy, Relapse Treatment); By Route of Administration (Subcutaneous, Intravenous, Oral); By End User (Hospitals, Specialty Hematology and Oncology Clinics, Outpatient Infusion Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

AL Amyloidosis Therapeutics Market: Daratumumab Standardization, Recurring Treatment, and Targeted Pipeline Expansion Accelerate Revenue Growth

The Global AL Amyloidosis Therapeutics Market is estimated at USD 3.58 billion in 2025 and... Read More

Published Date: JUL-2026 | No Of Pages:166 | $ 4485

Advanced Liver Cancer Market By Therapy Type (Targeted Therapy, Immunotherapy, Chemotherapy, Others); By Biomarker Status (Biomarker-Positive, Biomarker-Negative/Undifferentiated); By End User (Specialty Oncology Hospitals, General Hospitals & Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Advanced Liver Cancer Market is estimated to be valued at USD 10.8 billion in 2024 , projected to grow steadily and reach around USD 18.2 billion by 2030 , expanding at a ... Read More

Published Date: JAN-2026 | No Of Pages:156 | $ 4485

Advanced Cancer Pain Management Market By Product Type (Pharmaceutical Therapies, Medical Devices); By Route of Administration (Oral, Transdermal, Parenteral, Implantable Devices); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Advanced Cancer Pain Management Market is on a clear growth path, with a value of USD 9.8 billion in 2024 and projected to reach around USD 13.7 billion by 2030 with a Read More

Published Date: JAN-2026 | No Of Pages:179 | $ 4485

Acute Radiation Syndrome Market By Product Type (Pharmaceuticals, Medical Devices, Supportive Therapies); By Route of Administration (Intravenous, Oral); By Application (Emergency Response, Oncology Support, Industrial Accidents); By End User (Hospitals, Government Agencies, Military Units, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Radiation Syndrome (ARS) Market will expand at a steady CAGR of 6.5%, rising from $923 million in 2024 to $1.35 billion by 2030, fueled by r... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Acute Intermittent Porphyria Market By Product (Hemin Products [Hematin, Heme Arginate], RNA Interference Therapeutics [Givosiran], Carbohydrate-Based Therapies [Intravenous Glucose, Oral Carbohydrate Therapy], Supportive and Adjunctive Medicines [Analgesics, Antiemetics, Antihypertensive Medicines, Anticonvulsants], Diagnostic Products [Urinary PBG and ALA Tests, HMBS Genetic Tests]); By Application (Acute-Attack Treatment, Recurrent-Attack Prevention, Biochemical and Genetic Diagnosis, Long-Term Renal and Liver Monitoring); By End User (Hospitals and Emergency Departments, Porphyria and Rare-Disease Treatment Centres, Specialty Infusion Centres, Diagnostic Laboratories, Hospital and Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Acute Intermittent Porphyria Market: Recurrent Attacks, Monthly RNAi Treatment, and Reimbursement Restrictions Shape Revenue

The Global Acute Intermittent Porphyria Market was valued at USD 1.25 billion in 2025 and is... Read More

Published Date: JUL-2026 | No Of Pages:176 | $ 4485

Acrocallosal Syndrome Market By Treatment Approach (Gene Therapies, RNA-Based Therapies, Symptomatic Treatment); By End User (Hospitals, Diagnostic Labs, Home Care Providers, Pharmaceutical Companies, Government and Nonprofit Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acrocallosal Syndrome Market is valued at approximately USD 500 million in 2024 and is projected to reach USD 1.2 billion by 2030 , growi... Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Acoustic Neuroma Market By Treatment Type (Surgical Treatment, Radiosurgery [Gamma Knife, CyberKnife], Pharmacological Treatment, Watchful Waiting); By Diagnostic Modality (MRI, CT, Audiometry, Ultrasound, ENG); By End User (Hospitals, Specialized Clinics, Research Institutions, Diagnostic Imaging Centers, Patients); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acoustic Neuroma Market with USD 1.2 billion in 2024, expected to rise to USD 2.2 billion by 2030 growing at 6.5%, CAGR, influenced by acoustic ne... Read More

Published Date: JAN-2026 | No Of Pages:153 | $ 4485

Intrahepatic Cholangiocarcinoma Market By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Locoregional Treatment); By Route of Administration (Intravenous, Oral); By End User (Hospitals, Specialty Oncology Clinics, Infusion Centers); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Intrahepatic Cholangiocarcinoma Market is poised for steady expansion from USD 1.7 billion in 2024 to USD 2.9 billion by 2030, registering 9.3% CAGR driven by advancements... Read More

Published Date: JAN-2026 | No Of Pages:164 | $ 4485

Transient Ischemic Attack (TIA) Market By Diagnosis Type (Imaging [CT, MRI, Doppler Ultrasound], Electrocardiography [Standard ECG, Holter Monitoring], Blood Biomarkers); By Treatment Type (Antiplatelet Therapy, Anticoagulation, Surgical/Interventional); By End User (Hospitals, Neurology Clinics, Ambulatory Monitoring Providers, Telemedicine Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Transient Ischemic Attack (TIA) Market growing at 6.5% CAGR, valued at USD 2.1 billion in 2024 and forecast to reach USD 3.1 billion by 2030, shaped by Read More

Published Date: JAN-2026 | No Of Pages:179 | $ 4485

Merkel Cell Carcinoma Treatment Market By Treatment Type (Immunotherapy, Chemotherapy, Radiation Therapy, Surgery); By Stage of Disease (Early-Stage MCC, Advanced-Stage MCC); By End-User (Hospitals, Cancer Treatment Centers, Dermatology Clinics, Outpatient Clinics); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Merkel Cell Carcinoma Treatment Market is expected to be valued at USD 0.45 billion in 2024 and is projected to reach USD 0.88 billion by... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Inclusion Body Myositis Market By Product and Service (Rehabilitation Services, Mobility and Adaptive Equipment, Diagnostic Services, Pharmacological Therapies, Dysphagia Management Products and Procedures, Home Healthcare Services, Skilled Nursing and Long-Term Care Services); By Application (Muscle Strength and Mobility Management, Fall Prevention and Balance Support, Dysphagia and Aspiration Management, Diagnostic Evaluation and Disease Monitoring, Daily-Living and Functional Support, Clinical Trial and Investigational Treatment Management); By End User (Hospitals, Specialty Neuromuscular and Myositis Centers, Rehabilitation Centers, Home Healthcare Providers, Diagnostic Laboratories, Skilled Nursing and Long-Term Care Facilities, Academic and Clinical Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Inclusion Body Myositis Market: Progressive Disability Sustains Supportive-Care Revenue as Drug Developers Target Earlier Disease

The Global Inclusion Body Myositis Market will register moderate expansion at a CAGR of 5.6%, rising from USD 1.50 billion in 2025 to USD ... Read More

Published Date: JUL-2026 | No Of Pages:192 | $ 4485

Metabolic Acidosis Market By Treatment Type (Bicarbonate Therapy, Dialysis, Pharmaceutical Interventions); By Diagnostic Method (Blood Gas Analyzers, Urinalysis, Continuous Monitoring Devices); By End User (Hospitals, Dialysis Centers, Outpatient Care Clinics, Specialized Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Metabolic Acidosis Market is valued at USD 3.2 billion in 2024 and projected to reach USD 5.6 billion by 2030 at a CAGR of 8.9%, driven by rising chronic ... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Kidney Transplant Rejection Market By Product Type (Immunosuppressive Drugs, Biologics, Diagnostics, Digital Health Tools); By Diagnostic Approach (Tissue Biopsy, Blood-Based Biomarkers, Molecular Diagnostics, AI-Based Platforms); By End User (Transplant Centers, Community Hospitals, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Kidney Transplant Rejection Market is projected to grow from $2.8 billion in 2024 to nearly $4.5 billion by 2030, reflecting a CAGR of 8.3%, driven by Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Medulloblastoma Drug Market By Drug Type (Chemotherapy, Targeted Therapy, Immunotherapy, Biologics); By Route of Administration (Oral, Intravenous, Intrathecal); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); By End User (Pediatric Hospitals, General Hospitals, Diagnostic Imaging Centers, Research Institutions), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Medulloblastoma Drug Market is expected to grow from USD 1.5 billion in 2024 to USD 3.2 billion by 2030, at a 14% CAGR, fueled by advancements in medical ... Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

RNA Interference (RNAi) Drug Delivery Market By Drug Type (siRNA, miRNA); By Delivery Platform (Lipid Nanoparticles, GalNAc Conjugates, Polymeric Carriers, Exosomes); By Application (Genetic & Rare Diseases, Oncology, Cardiovascular & Metabolic, Neurological Disorders); By Route of Administration (Intravenous, Subcutaneous, Intrathecal/Inhalable); By End User (Hospitals, Specialty Clinics, Homecare Settings, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Executive Introduction and Strategic Overview

The Global RNA Interference (RNAi) Drug Delivery Market is projected to grow at an 18.9% CAGR, expanding from USD 1.47 billion in 2024 to USD 4.12... Read More

Published Date: SEP-2025 | No Of Pages:190 | $ 4485

Cancer Cachexia Market By Therapeutic Approach (Pharmacological Therapies, Nutritional Interventions, Multimodal Therapy); By Product Type (Pharmaceuticals, Nutraceuticals & Medical Nutrition, Medical Devices & Exercise Aids); By End User (Hospitals & Cancer Specialty Centers, Ambulatory & Outpatient Clinics, Homecare & Palliative Services); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Cachexia Market is expected to grow at a CAGR of 6.8%, expanding from USD 3.8 billion in 2024 to nearly USD 5.64 billion by 2030, fueled by advance... Read More

Published Date: DEC-2025 | No Of Pages:178 | $ 4485

CD Antigen Cancer Therapy Market By Antigen Target (CD19, CD20, CD22, CD33, CD47, CD123, Others); By Therapy Type (Monoclonal Antibodies, CAR-T Therapies, Bispecific Antibodies, Antibody-Drug Conjugates); By Cancer Type (Leukemia, Lymphoma, Multiple Myeloma, Solid Tumors); By Route of Administration (Intravenous, Subcutaneous); By End User (Academic Medical Centers, Specialty Cancer Hospitals, General Hospitals, Cell Therapy Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

CD Antigen Cancer Therapy Market: CD19, CD20, CD22, CD33, CD123, and CD3-Redirected Platforms Reshape Targeted Oncology (Last Updated on: June-2026)

The Global CD Antigen Cancer Therapy Market was valued at USD 3.9 billion in 2024 and is projected to reach USD 9.... Read More

Published Date: DEC-2025 | No Of Pages:159 | $ 4485

Penile Cancer Treatment Market By Treatment Type (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy); By Route of Administration (Oral, Injectable, Localized); By End User (Hospitals, Specialty Cancer Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Penile Cancer Treatment Market valued at USD 280 million in 2024 and expected to hit USD 415 million by 2030 at 6.8% CAGR, highlighting market siz... Read More

Published Date: DEC-2025 | No Of Pages:196 | $ 4485

Egg Donation Market By Donor Type (Fresh Donor Eggs, Frozen Donor Eggs); By Service Channel (Fertility Clinics & ART Centers, Egg Banks & Agencies, Hospitals & Maternity Centers); By End User (Heterosexual Couples, Single Women & Same-Sex Couples, Research & Academic Use); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Egg Donation Market valued at USD 2.5 billion in 2024 and projected to reach USD 4.2 billion by 2030 at CAGR of 8.1%, reflecting fertility service... Read More

Published Date: DEC-2025 | No Of Pages:163 | $ 4485

Drug Addiction Treatment Market By Treatment Type (Pharmacological, Non-Pharmacological); By Drug Type (Opioids, Alcohol, Nicotine, Stimulants, Polysubstance); By End User (Hospitals, Specialty Clinics, Digital Health Platforms, Correctional Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Drug Addiction Treatment Market valued at $19.2 billion in 2024 and projected to reach $31.7 billion by 2030 at CAGR of 8.7%, fueled by rehabilita... Read More

Published Date: DEC-2025 | No Of Pages:153 | $ 4485

Ascites Market By Treatment Type (Diuretics, Large-Volume Paracentesis, Albumin Therapy, Transjugular Intrahepatic Portosystemic Shunt [TIPS], Implantable Pump Systems, Indwelling Drainage Catheters, Liver Transplantation, Investigational Therapies); By Disease Type (Cirrhotic Ascites, Malignant Ascites, Cardiac Ascites, Renal Ascites, Other Ascites Conditions); By End User (Hospitals, Liver Transplant Centers, Specialty Clinics, Ambulatory and Outpatient Care Centers, Home-Care Settings); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Ascites Market: Recurring Fluid Management Creates a Procedure-Led Care Economy

The Global Ascites Market was valued at USD 1.56 billion in 2025 and is projected to reach USD 2.46 billion by 2032, expanding at a CAGR of 6.7% during 2026–2032, according to Strate... Read More

Published Date: DEC-2025 | No Of Pages:161 | $ 4485

Peptide Cancer Vaccine Market By Vaccine Type (Synthetic Peptide Vaccines, Personalized Peptide Vaccines); By Cancer Type (Melanoma, Non-Small Cell Lung Cancer, Triple-Negative Breast Cancer, Pancreatic Cancer, Glioblastoma); By Delivery Mechanism (Peptides Alone, Peptides with Adjuvants, Peptides with RNA/DNA Vectors); By End User (Academic Hospitals, Specialty Oncology Clinics, Biopharmaceutical Companies, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Peptide Cancer Vaccine Market valued at USD 1.2 billion in 2024 and expected to reach USD 4.6 billion by 2030, expanding with 24.9% CAGR, driven by Read More

Published Date: DEC-2025 | No Of Pages:154 | $ 4485

Pneumothorax Treatment Market By Product Type (Chest Drainage Systems [Wet Suction Systems, Dry Suction Systems, Portable and Ambulatory Drainage Systems, Digital Chest Drainage Systems], Chest Tubes and Pleural Catheters, Needle Aspiration Devices, Pleurodesis Products, Thoracic Surgical Devices, Accessories and Consumables); By Application (Primary Spontaneous Pneumothorax, Secondary Spontaneous Pneumothorax, Traumatic Pneumothorax, Iatrogenic Pneumothorax, Neonatal Pneumothorax, Postoperative Pneumothorax); By Treatment Type (Conservative Management, Needle Aspiration, Chest-Tube Drainage, Ambulatory Drainage, Chemical Pleurodesis, Surgical Treatment); By End User (Hospitals, Trauma and Emergency Care Centers, Ambulatory Surgical Centers, Specialty Respiratory and Thoracic Clinics, Ambulatory Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Pneumothorax Treatment Market: Complex Cases, Ambulatory Care, and Safety Standards Redirect Revenue

The Global Pneumothorax Treatment Market was valued at USD 2.23 billion in 2025 and is projected to reach USD 3.37 billion by 2032, growing at a CAGR of 6.1%, accordin... Read More

Published Date: JUL-2026 | No Of Pages:157 | $ 4485

Acute Respiratory Infection Market By Infection Type (Upper Respiratory Tract Infections, Lower Respiratory Tract Infections); By Pathogen Type (Viral, Bacterial, Others); By Treatment Type (Antibiotics, Antivirals, Immunomodulators, Supportive Care); By End User (Hospitals, Clinics, Ambulatory Care Centers, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Respiratory Infection Market is projected to grow from USD 69.1 billion in 2024 to USD 94.6 billion by 2030, registering a steady 5.4% CAGR, driven ... Read More

Published Date: DEC-2025 | No Of Pages:197 | $ 4485

Aicardi Goutieres Syndrome Market By Treatment Type (Symptomatic Therapy, Experimental/Investigational Therapies); By Route of Administration (Oral, Parenteral, Emerging Routes); By End User (Specialty Hospitals, Academic & Research Institutes, Diagnostic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aicardi Goutieres Syndrome (AGS) Market valued at USD 92 million in 2024 and projected to reach USD 154 million by 2030 at 7.8%, CAGR, driven by t... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Chronic Venous Insufficiency Treatment Market By Treatment Type (Compression Therapy, Pharmacological Therapy, Endovenous Ablation, Sclerotherapy, Surgical Vein Stripping); By Disease Severity (Early-Stage CVI, Moderate CVI, Severe CVI); By End User (Hospitals, Specialized Vascular Clinics, Ambulatory Surgical Centers, Diagnostic & Primary Care Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Venous Insufficiency Treatment Market valued at USD 3.9 billion in 2024 and projected to reach USD 6.1 billion by 2030 at 6.5% CAGR, boosted by Read More

Published Date: DEC-2025 | No Of Pages:177 | $ 4485

Chronic Thromboembolic Pulmonary Hypertension Market By Treatment Modality (Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, Pharmacotherapy); By Drug Class (Soluble Guanylate Cyclase Stimulators, Prostacyclin Analogs, Endothelin Receptor Antagonists, Anticoagulants); By End User (Specialized CTEPH Centers, Tertiary Hospitals, General Hospitals, Diagnostic & Outpatient Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Market will witness a robust CAGR of 6.8% , valued at USD 1.7 billion in 2024 , exp... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Cocaine Intoxication Treatment Market By Treatment Type (Benzodiazepines, Cardiovascular Stabilizers, Antipsychotics, Enzyme-Based Antidotes, Other Emerging Pharmacotherapies); By Route of Administration (Intravenous, Intramuscular, Oral, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation and Forecast, 2026–2032

Cocaine Intoxication Treatment Market: Emergency Demand, Fentanyl Co-Exposure, and Antidote Development Shape Commercial Opportunity

The Global Cocaine Intoxication Treatment Market was valued at USD 75 million in 2025 and is projected to reach USD 118.02 million by 2... Read More

Published Date: JUL-2026 | No Of Pages:195 | $ 4485

Complement 3 Glomerulopathy Treatment Market By Drug Class (Complement Inhibitors, Immunosuppressants, Corticosteroids, Others); By Route of Administration (Intravenous, Oral, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Complement 3 Glomerulopathy Treatment Market valued at USD 615.0 million in 2024 and projected to reach USD 1.1 billion by 2030 at 10.2%, CAGR, with Read More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

Cold Agglutinin Disease Treatment Market By Therapy Class (Complement Inhibitors, B-Cell-Directed Therapies, Immunosuppressants, Other Emerging Treatments); By Route of Administration (Intravenous, Oral, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Cold Agglutinin Disease Treatment Market: Enjaymo Revenue, Durable B-Cell Therapy, and Oral Pipeline Programs Reshape Competition

The Global Cold Agglutinin Disease Treatment Market was valued at USD 148.96 million in 2025 and is expected to reach USD 343.56 million b... Read More

Published Date: JUL-2026 | No Of Pages:200 | $ 4485

Vernal Keratoconjunctivitis Market By Drug Class (Antihistamines & Mast Cell Stabilizers, Corticosteroids, Immunomodulators, Biologics); By Route of Administration (Eye Drops, Gels, Ocular Inserts); By Patient Age Group (Pediatric, Adolescent, Adult-Onset); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Vernal Keratoconjunctivitis Market is projected to grow at a CAGR of 6.8% , valued at USD 332.0 million in 2024 , and ex... Read More

Published Date: DEC-2025 | No Of Pages:190 | $ 4485

Rare NRG1 Fusion Market By Therapy Type (Monoclonal Antibodies, Tyrosine Kinase Inhibitors, RNA Therapies & Antibody-Drug Conjugates); By Cancer Type (Non-Small Cell Lung Cancer, Pancreatic Cancer, Others); By Diagnostic Method (CGP via NGS, FISH & RT-PCR); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Rare NRG1 Fusion Market is forecasted to grow at a dynamic CAGR of 37.8%, rising from $ 187.0 million in 2024 to $1.42 billion by 2030, supported by Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Non-Cystic Fibrosis Bronchiectasis Market By Treatment Type (DPP1 Inhibitors, Antibiotics, Mucoactive and Airway-Clearance Therapies, Bronchodilators, Corticosteroids, Biologics, Inhaled Immunotherapies, Bacteriophage Therapies, Other Supportive Treatments); By Route of Administration (Oral, Inhaled and Nebulized, Intravenous, Subcutaneous, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Drug Stores, Specialty Pharmacies, Online Pharmacies); By Patient Type (Adults, Adolescents Aged 12–17 Years); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Non-Cystic Fibrosis Bronchiectasis Market - First Approval Moves Bronchiectasis Beyond Supportive Care

The Global Non-Cystic Fibrosis Bronchiectasis Market was valued at USD 2.28 billion in 2025 and is projected to reach USD 6.18 billion by 2032, expanding at a CAGR o... Read More

Published Date: Aug-2026 | No Of Pages:168 | $ 4485

Neoantigen Cancer Vaccine Market By Technology Platform (mRNA-based, Peptide-based, DNA-based, Dendritic Cell-based); By Cancer Type (Melanoma, NSCLC, Colorectal, Pancreatic, Glioblastoma, Others); By Delivery Mechanism (Lipid Nanoparticle, Intradermal Injection, Electroporation); By End User (Academic Cancer Centers, Specialty Oncology Hospitals, CROs, Immunotherapy Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Neoantigen Cancer Vaccine Market will register rapid growth at a compelling CAGR of 24.7% from 2024 to 2030, growing from USD 1.2 billion in 2024 to USD 4.5 billio... Read More

Published Date: DEC-2025 | No Of Pages:192 | $ 4485

mRNA Therapeutics Market By Product Type (mRNA Vaccines, mRNA Therapeutics); By Application (Infectious Diseases, Oncology, Genetic Disorders, Autoimmune Diseases, Cardiovascular and Others); By Route of Administration (Intramuscular, Intravenous, Inhalation/Intranasal); By End User (Hospitals & Academic Centers, Public Health Agencies, Retail Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global mRNA Therapeutics Market is poised for high growth, increasing from USD 45.2 billion in 2024 to USD 98.7 billion by 2030, registering a CAGR of 13.9%, dri... Read More

Published Date: DEC-2025 | No Of Pages:173 | $ 4485

Intratumoral Cancer Therapies Market By Therapy Type (Oncolytic Viruses, Cytokine-Based Therapies, Gene Therapies, Small Molecule Injectables); By Cancer Type (Melanoma, Head and Neck, Breast, Lung, Pancreatic, Brain Tumors); By Route of Administration (Image-Guided Injection, Intraoperative Delivery, Endoscopic Injection); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Intratumoral Cancer Therapies Market is projected to experience dynamic growth at a solid CAGR of 10.6%, valued at USD 1.3 billion in 2024, and projected to surpass Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Interstitial Lung Disease Market By Disease Type (IPF, CTD-ILD, HP, Occupational/Environmental, Sarcoidosis, Drug-Induced, Others); By Drug Class (Antifibrotics, Corticosteroids, Immunosuppressants, Biologics, Novel Agents); By Route of Administration (Oral, Inhalation, Injectable); By Diagnostic Tool (HRCT, PFTs, Biomarkers, Genetic Testing, Lung Biopsy); By End User (Tertiary Hospitals, Specialist Clinics, Imaging Centers, Community Hospitals, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Interstitial Lung Disease Market is anticipated to grow at a sustainable CAGR of around 6.1%, increasing from USD 4.7 billion in 2024 to nearly USD 6.7 billion by ... Read More

Published Date: DEC-2025 | No Of Pages:196 | $ 4485

IgA Nephropathy Market By Therapy Type (Corticosteroid-Sparing Therapies, Endothelin Receptor Antagonists, Complement Inhibitors, Supportive Care); By Route of Administration (Oral, Injectable); By End User (Academic and Tertiary Hospitals, Specialty Nephrology Clinics, Retail and Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

IgA Nephropathy Market: Kidney-Function Evidence and Immune-Targeted Therapies Reshape Commercial Competition

The Global IgA Nephropathy Market is set to register strong expansion at a CAGR of 18.28%, growing from USD 135.61 million in 2025 to USD 439... Read More

Published Date: JUL-2026 | No Of Pages:177 | $ 4485

HER2 Positive Gastric Cancer Market By Therapy Type (Monoclonal Antibodies, Antibody-Drug Conjugates, Tyrosine Kinase Inhibitors, Immunotherapies); By Line of Treatment (First-Line, Second-Line, Third-Line & Beyond); By Diagnostic Modality (IHC, FISH, NGS); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Infusion Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global HER2 Positive Gastric Cancer Market expanding at 6.8% CAGR, forecast to grow from USD 3.7 billion in 2024 to USD 5.5 billion by 2030, driven by ta... Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

Hematopoietic Stem Cell Transplantation (HSCT) Market By Transplant Type (Autologous, Allogeneic); By Stem Cell Source (Peripheral Blood, Bone Marrow, Umbilical Cord Blood); By Clinical Application (Blood Cancers, Bone Marrow Failure and Hemoglobin Disorders, Immune Deficiencies and Rare Genetic Diseases); By End User (Academic Hospitals, Specialty Transplant Centers, General Hospitals, Research Institutions); By Geography, Segment Revenue Estimation and Forecast, 2026–2032.

Hematopoietic Stem Cell Transplantation Market: Alternative Donors, Engineered Grafts, and Complication Control Reshape Growth

The Global Hematopoietic Stem Cells Transplantation (HSCT) Market is projected to grow from USD 3.21 billion in 2025 to USD 6.06 billion by 2... Read More

Published Date: JUL-2026 | No Of Pages:166 | $ 4485

Fibromyalgia Treatment Market By Drug Class (SNRIs, Anticonvulsants, Tricyclic Antidepressants, Muscle Relaxants, Others); By Route of Administration (Oral, Topical, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fibromyalgia Treatment Market will grow at a compound annual growth rate of 5.2 %, rising from USD 3.6 billion in 2024 to USD 4.88 billion by 2030, fueled... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

DiGeorge Syndrome Drug Market By Drug Class (Immunomodulators and Immunoglobulins, Hormone Replacement Therapies, Antipsychotics and Behavioral Medications, Supportive Medications); By Therapeutic Target (Immune System Dysfunction, Endocrine and Metabolic Dysfunction, Neurodevelopmental and Psychiatric Symptoms, Congenital Heart Defects and Surgical Support); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail Pharmacies and Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global DiGeorge Syndrome Drug Market valued at USD 328.0 million in 2024 and projected to reach USD 522.0 million by 2030 at 8.1% CAGR, reflecting 22q11.... Read More

Published Date: DEC-2025 | No Of Pages:175 | $ 4485

Cutaneous Lupus Erythematosus Market By Disease Subtype (Acute CLE, Subacute CLE, Chronic CLE); By Treatment Class (Topical Agents, Antimalarials, Immunosuppressants, Biologics & Small Molecules); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cutaneous Lupus Erythematosus (CLE) Market will witness steady expansion at a CAGR of 6.4%, reaching USD 3.1 billion by 2030 from USD 2.1 billion in 2024,... Read More

Published Date: DEC-2025 | No Of Pages:171 | $ 4485

Chronic Spontaneous Urticaria Treatment Market By Treatment Type (Antihistamines, Biologics, Leukotriene Receptor Antagonists, Corticosteroids, Others); By Route of Administration (Oral, Injectable, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Spontaneous Urticaria (CSU) Treatment Market is projected to expand steadily between 2024 and 2030, driven by a combination of rising disease prev... Read More

Published Date: DEC-2025 | No Of Pages:174 | $ 4485

Chronic Rhinosinusitis With Nasal Polyps Market By Treatment Type (Corticosteroids, Biologics, Surgery, Others); By Route of Administration (Intranasal, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Rhinosinusitis With Nasal Polyps Market will expand at a stable CAGR of 6.8%, growing from USD 5.1 billion in 2024 to USD 7.6 billion by 2030, fue... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Chronic Obstructive Pulmonary Disease (COPD) Treatment Market By Drug Class (Bronchodilators, Corticosteroids, PDE-4 Inhibitors, Combination Therapies, Others); By Route of Administration (Inhalation, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market is projected to grow at a steady CAGR of 6.1%, with an estimated value of USD 20.1 billion in 2024 and a fore... Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

Chronic Lymphocytic Leukemia Market By Therapy Type (BTK Inhibitors, BCL2 Inhibitors, Anti-CD20 Monoclonal Antibodies, Chemoimmunotherapy, CAR-T and Other Emerging Therapies); By Line of Therapy (First-Line Treatment, Relapsed and Refractory Treatment); By Diagnostics and Monitoring (Flow Cytometry, Cytogenetic Testing, TP53/IGHV Testing, MRD Assays, Others); By End User (Hospitals, Specialist Hematology Clinics, Cancer Treatment Centers, Outpatient Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Chronic Lymphocytic Leukemia Market: Targeted Treatment Sequencing Reshapes Long-Term Revenue

The Global Chronic Lymphocytic Leukemia Market was valued at approximately USD 8.72 billion in 2025 and is projected to reach USD 13.37 billion by 2032, expanding at a CAGR o... Read More

Published Date: JUL-2026 | No Of Pages:177 | $ 4485

Chronic Inducible Urticaria Treatment Market By Drug Class (Antihistamines, Leukotriene Receptor Antagonists, Biologics, Immunosuppressants); By Route of Administration (Oral, Subcutaneous, Others); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Chronic Inducible Urticaria Treatment Market is projected to rise from $1.3 billion in 2024 to $2.1 billion by 2030, registering a CAGR of 8.2%, driven by... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Chondrosarcoma Market By Type (Conventional, Dedifferentiated, Mesenchymal, Clear Cell); By Treatment Modality (Surgery, Radiation Therapy, Targeted Therapy, Immunotherapy); By End User (Academic Hospitals, Orthopedic Oncology Centers, Community Hospitals, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chondrosarcoma Market is projected to grow from USD 1.2 billion in 2024 to nearly USD 1.80 billion by 2030, reflecting a CAGR of 7.3 %, driven by ... Read More

Published Date: DEC-2025 | No Of Pages:169 | $ 4485

Chemotherapy-Induced Diarrhea Treatment Market By Treatment Type (Anti-Diarrheal Agents, Oral Rehydration Solutions, Probiotics, Biologics & Emerging Therapies); By Drug Class (Antimotility Agents, Somatostatin Analogues, Antisecretory Agents, Intestinal-Protective Therapies, Microbiome-Targeted Therapies); By Chemotherapy Regimen (Fluoropyrimidines, Irinotecan, Combination Therapies, Others); By End User (Hospitals & Oncology Centers, Outpatient Clinics & Homecare, Pharmacies & Retail); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Chemotherapy-Induced Diarrhea Treatment Market: Oncology Supportive-Care Market Driven by High-Risk Chemotherapy Regimens

The Global Chemotherapy-Induced Diarrhea Treatment Market is projected to witness a robust CAGR of 8.1%, valued at USD 83 million in 2025, expecte... Read More

Published Date: JUN-2026 | No Of Pages:160 | $ 4485

Chemotherapy Induced Peripheral Neuropathy Treatment Market By Drug Class (Antidepressants, Anticonvulsants, Topical Agents, Opioids, Neuroprotective Agents); By Mechanism of Action (Pain Modulation, Neuroprotection, Nerve Regeneration); By Route of Administration (Oral, Injectable, Transdermal); By Geography, Segment Revenue Estimation, Forecast, 2025–2030.

Introduction And Strategic Context

The Global Chemotherapy Induced Peripheral Neuropathy ( CIPN ) Treatment Market is projected to grow at a CAGR of 7.3 %, reaching a... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Checkpoint Inhibitor Refractory Cancer Market By Therapy Type (T-cell Engagers, Next-Generation Checkpoint Modulators, Cell Therapies, Small Molecule Immunomodulators, Combination Therapies); By Cancer Type (Melanoma, NSCLC, RCC, HNSCC, Others); By End User (Academic Cancer Centers, Specialty Oncology Clinics, General Hospitals, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Checkpoint Inhibitor Refractory Cancer Market will witness a robust CAGR of 9.6%, valued at USD 8.3 billion in 2024, and expected to reach around USD 14.4 billion ... Read More

Published Date: DEC-2025 | No Of Pages:171 | $ 4485

CD38 Monoclonal Antibody Drugs Market By Therapy Type (Monotherapy, Combination Therapy); By Indication (Multiple Myeloma, Chronic Lymphocytic Leukemia, Autoimmune Disorders, Other Hematologic Malignancies); By Distribution Channel (Hospital Pharmacies, Community Oncology Clinics, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD38 Monoclonal Antibody Drugs Market is projected to expand steadily between 2024 and 2030 , with an estimated value of USD 8.1 billion in 2024 and likel... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Catheter Related Bloodstream Infection Market By Product Type (Antimicrobial Catheters, CHG Dressings, Needleless Connectors, Catheter Lock Solutions); By Pathogen Type (Gram-Positive Bacteria, Gram-Negative Bacteria, Fungal Pathogens); By End User (Hospitals, Dialysis Clinics, Infusion Centers, Home Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Catheter-Related Bloodstream Infection (CRBSI) Market is projected to grow at a steady CAGR of 6.5%, reaching USD 2.35 billion by 2030 from USD 1.6 billion in 2024... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Cardiac Amyloidosis Market By Product Type (Transthyretin Stabilizers, RNA Interference Therapies, Antisense Oligonucleotides, Monoclonal Antibodies, Diagnostics); By Application (Transthyretin Amyloidosis [Hereditary, Wild-type], Light Chain Amyloidosis); By End User (Hospitals, Specialty Cardiac Centers, Diagnostic Laboratories, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiac Amyloidosis Market will grow at a CAGR of 10.8% , valued at USD 4.2 billion in 2024 , and projected to reach USD 7.8 billion by 2030 , according t... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Cancer Anorexia Market By Product Type (Appetite Stimulants, Corticosteroids, Progestogens, Cannabinoids, Nutraceuticals, Biologics/Peptides); By Route of Administration (Oral, Injectable, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Anorexia Market valued at USD 2.9 billion in 2024 and expected to reach USD 4.3 billion by 2030, expanding with 6.8% CAGR, propelled by onc... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

Bullous Keratopathy Market By Treatment Type (Corneal Transplantation [DMEK, DSAEK, Penetrating Keratoplasty], Pharmacological Therapy, Artificial Corneas, Supportive & Symptomatic Treatment); By Cause (Post-Cataract Surgery, Fuchs’ Dystrophy, Trauma, Infection, Congenital Disorders); By End User (Specialty Eye Hospitals, General Hospitals, ASCs, Academic/Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bullous Keratopathy Market is projected to grow steadily from USD 1.12 billion in 2024 to reach around USD 1.61 billion by 2030 , reflecting a CAG... Read More

Published Date: DEC-2025 | No Of Pages:157 | $ 4485

Bronchopulmonary Dysplasia (BPD) Treatment Market By Treatment Type (Caffeine Citrate Therapy, Pulmonary Surfactant Therapy, Corticosteroid Therapy, Diuretics, Bronchodilators, Pulmonary Vasodilators, Vitamin A Supplementation, Oxygen Therapy, Non-Invasive Respiratory Support, Mechanical Ventilation, Biologics and Growth-Factor Therapies, Cell-Based and Exosome Therapies); By Application (BPD Prevention in High-Risk Preterm Infants, Established Bronchopulmonary Dysplasia, Moderate-to-Severe Bronchopulmonary Dysplasia, Ventilator-Dependent Bronchopulmonary Dysplasia, BPD-Associated Pulmonary Hypertension, Post-Discharge Respiratory Management); By End User (Neonatal Intensive Care Units, Children’s Hospitals, Maternity and Perinatal Care Hospitals, Paediatric Pulmonology Clinics, Paediatric Cardiology Clinics, Specialty Neonatal Follow-Up Centres, Home Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Bronchopulmonary Dysplasia Treatment Market: Negative Budesonide Trials Raise the Evidence Bar for Neonatal Biologics

The Global Bronchopulmonary Dysplasia (BPD) Treatment Market was valued at USD 1.30 billion in 2025 and is projected to reach ... Read More

Published Date: JUL-2026 | No Of Pages:195 | $ 4485

BRCA Mutations Treatment Market By Treatment Type (PARP Inhibitors, Hormonal Therapy, Chemotherapy, Targeted Combinations); By Cancer Type (Breast Cancer, Ovarian Cancer, Prostate Cancer, Pancreatic and Others); By End User (Hospitals and Cancer Centers, Specialty Oncology Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global BRCA Mutations Treatment Market is projected to reach a value of $5.8 billion in 2024 , with expectations to surpass $10.2 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:192 | $ 4485

Bone Metastasis Market By Treatment Type (Pharmaceuticals [Bisphosphonates, RANKL Inhibitors, Radiopharmaceuticals], Radiation Therapy, Surgical Interventions, Supportive Care); By Cancer Type (Breast Cancer, Prostate Cancer, Lung Cancer, Kidney Cancer, Thyroid & Others); By End User (Hospitals & Cancer Centers, Community Oncology Clinics, Specialty Orthopedic Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bone Metastasis Market is expected to witness sustained growth, reaching USD 18.7 billion in 2024 and anticipated to cross USD 27.9 billion by 2030, reflecting a C... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Blepharitis Market By Disease Subtype (Posterior Blepharitis/Meibomian Gland Dysfunction, Demodex Blepharitis, Anterior Blepharitis, Mixed Blepharitis); By Treatment Type (Prescription Pharmaceuticals, Lid Hygiene Products, In-Office Procedures, Device-Based Home Therapies); By End User/Care Setting (Ophthalmology Clinics, Optometry Clinics, Hospitals, Home Care Users); By Distribution Channel (Retail Pharmacies & Drug Stores, Hospital Pharmacies, Online Platforms, Clinic-Based Dispensing); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Blepharitis Market: Disease-Specific Treatment Converts a Fragmented Care Category into Measurable Revenue

The Global Blepharitis Market is valued at USD 1.10 billion in 2025 and is projected to reach USD 1.67 billion by 2032, growing at a CAGR of 6.1%, according to S... Read More

Published Date: JUL-2026 | No Of Pages:150 | $ 4485

Biliary Atresia Market By Treatment Type (Surgical Interventions, Liver Transplantation, Pharmacological Therapies); By Diagnosis Stage (Early Diagnosis, Delayed Diagnosis); By End User (Tertiary Pediatric Hospitals, Specialty Liver Transplant Units, General Hospitals with Pediatric Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biliary Atresia Market is projected to expand steadily between 2024 and 2030, driven by rising awareness of neonatal liver disorders, earlier diagnostic interventions, and ongoing advances... Read More

Published Date: DEC-2025 | No Of Pages:197 | $ 4485

Beta Thalassemia Market By Therapy Type (Blood Transfusions, Iron Chelation Therapy, Gene Therapy & Gene Editing, Bone Marrow/Stem Cell Transplantation); By Route of Administration (Intravenous, Oral); By End User (Hospitals & Hematology Centers, Specialty Clinics, Retail & Online Pharmacies, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Beta Thalassemia Market is projected to expand steadily between 2024 and 2030, valued at USD 1.9 billion in 2024 and expected to reach USD 3.1 billion by 2030, reflecting ... Read More

Published Date: DEC-2025 | No Of Pages:161 | $ 4485

Benign Prostatic Hyperplasia Treatment Market By Therapy Type (Pharmacological, Minimally Invasive Surgical Therapies, Surgical Procedures); By Procedure Setting (Hospitals, Ambulatory Surgical Centers, Urology Clinics); By End User (Hospitals & Teaching Institutions, Specialty Urology Centers, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Benign Prostatic Hyperplasia Treatment Market: Generic Drug Volume, Procedure Durability, and Minimally Invasive Device Expansion Reshape Urology Competition

The Global Benign Prostatic Hyperplasia Treatment Market was valued at USD 12.4 billion in 2025 and is project... Read More

Published Date: JUL-2026 | No Of Pages:153 | $ 4485

AXL Receptor Tyrosine Kinase Inhibitors Market By Molecule Type (Small Molecule Inhibitors, Monoclonal Antibodies, Antibody-Drug Conjugates); By Application (Oncology, Fibrosis, Inflammatory Diseases); By Route of Administration (Oral, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

AXL Inhibitors Market Advances as Oncology Pipelines Target Drug Resistance, Metastasis and Immune Evasion (Last Updated On: June-2026)

The Global AXL Receptor Tyrosine Kinase (RTK) Inhibitors Market valued at USD 1.2 billion in 2024 and set to reach USD 2.8 billion b... Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

Axial Spondyloarthritis Market By Treatment Type (TNF Inhibitors, IL-17 Inhibitors, JAK Inhibitors, NSAIDs, Conventional DMARDs, Other Therapies); By Disease Type (Radiographic Axial Spondyloarthritis, Non-Radiographic Axial Spondyloarthritis); By Route of Administration (Injectable, Oral, Intravenous); By End User (Hospitals, Rheumatology Clinics, Specialty Clinics, Homecare Settings); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Axial Spondyloarthritis Market: Earlier Diagnosis Expands Treatment Demand While Biosimilars Reset the Revenue Model

The Global Axial Spondyloarthritis (AxSpA) Market will experience consistent growth at a CAGR of 7.4%, increasing from USD 5.58 billion in 2025 to USD ... Read More

Published Date: JUL-2026 | No Of Pages:162 | $ 4485

Trodelvy Market By Indication (Triple-Negative Breast Cancer, HR+/HER2- Breast Cancer, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Others); By Line of Therapy (Second-Line, Third-Line and Beyond, Maintenance); By Distribution Channel (Hospital Pharmacies, Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Trodelvy Market valued at USD 1.62 billion in 2024 and anticipated to grow to USD 4.95 billion by 2030 at 20.1% CAGR, featuring Trodelvy marketRead More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

PIM Kinase Targeted Therapies Market By Therapy Type (Monotherapy, Combination Therapies); By Target Type (Selective PIM1 Inhibitors, Dual PIM/FLT3 Inhibitors, Pan-PIM Kinase Inhibitors); By Indication (Myelofibrosis, Aggressive B-Cell Lymphoma, Multiple Myeloma, Other Hematological Malignancies); By Development Stage (Clinical Stage Therapies, Preclinical Pipeline Candidates); By End User (Hospitals, Academic Cancer Centers, Specialty Oncology Clinics, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

PIM Kinase Targeted Therapies Market: Pipeline Progress Creates a New Specialist Oncology Opportunity

The Global PIM Kinase Targeted Therapies Market is estimated to reach USD 858.78 million in 2025 and is projected to ... Read More

Published Date: JUL-2026 | No Of Pages:196 | $ 4485

Lupus Nephritis Treatment Market By Drug Class (Immunosuppressants, Biologics, Corticosteroids, ACE Inhibitors & ARBs, Antimalarials); By Route of Administration (Oral, Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lupus Nephritis Treatment Market is projected to grow at a CAGR of 10.4%, expanding from USD 1.6 billion in 2024 to approximately USD 2.9 billion ... Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

CD40 Targeted Therapies Market By Therapy Type (Monoclonal Antibodies, Fusion Proteins, Small Molecules); By Indication (Oncology, Autoimmune Diseases, Transplantation); By Route of Administration (Intravenous, Subcutaneous); By End User (Hospitals, Specialty Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD40 Targeted Therapies Market is projected to grow at a robust CAGR of 11.8%, reaching an estimated valuation of USD 3.9 billion by 2030... Read More

Published Date: DEC-2025 | No Of Pages:169 | $ 4485

Protein Misfolding & Aggregation Disorder Therapies (PMADT) Market By Target Protein (Amyloid-β, Tau, α-Synuclein, Huntingtin, TDP-43, Others); By Therapeutic Modality (Monoclonal Antibodies, RNA/Antisense Therapies, Small Molecule Modulators, Gene Therapy & Advanced Platforms); By Indication (Alzheimer’s, Parkinson’s, ALS, Huntington’s, Rare Proteinopathies); By Line of Therapy; By Region, Segment Revenue Estimation, Forecast, 2025–2035

1. Introduction and Strategic Context

The Global Protein Misfolding & Aggregation Disorder Therapies (PMADT) Market is projected to reach USD 1.7 billion by 2035, up from around USD 0.6 billion in 2025, growing at... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

PLK Targeted Therapies Market By Drug Type (PLK1 Inhibitors, Multi-Kinase Inhibitors); By Cancer Indication (Acute Myeloid Leukemia, Prostate Cancer, Ovarian Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Other Indications Led by Colorectal Cancer); By Treatment Line (First-Line Therapy, Second-Line Therapy, Maintenance and Combination Therapy); By Therapy Approach (Monotherapy, Combination Therapy, Biomarker-Guided Therapy); By End User (Hospitals, Specialty Oncology Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

PLK Targeted Therapies Market - Selective PLK Programs Move the Market Toward Its First Commercial Validation

The PLK targeted therapies market remains an emerging clinical-stage market rather than an established prescription category. No direct PLK inhibitor was iden... Read More

Published Date: JUL-2026 | No Of Pages:167 | $ 4485

Gamma Delta T Cell Cancer Therapy Market By Therapy Type (Allogeneic, Autologous); By Cancer Indication (Hematologic Malignancies, Solid Tumors); By Delivery Method (Non-Engineered, Genetically Modified); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gamma Delta T Cell Cancer Therapy Market valued at USD 318 million in 2024 and projected to reach USD 2.1 billion by 2030 at CAGR of 32.6%, combining Read More

Published Date: DEC-2025 | No Of Pages:163 | $ 4485

Cancer Photodynamic Therapy (PDT) Market By Product Type (Photosensitizing Agents, Light Delivery Systems); By Cancer Application (Lung Cancer, Esophageal Cancer, Bladder Cancer, Head & Neck Cancer, Skin Cancer, Others); By End User (Hospitals, Cancer Specialty Centers, Ambulatory Surgical Centers, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Cancer Photodynamic Therapy Market: Drug-Light Oncology Platform Shaped by Local Tumor Access and Precision Treatment (Last Updated on: June-2026)

The Global Cancer Photodynamic Therapy (PDT) Market is projected to grow at a CAGR of 8.9%, rising from USD 1.5 billion i... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

CD5 Targeting Therapies Market By Therapy Type (Monoclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates, Small Molecule Inhibitors); By Indication (Hematologic Malignancies, Autoimmune Disorders, Graft-Versus-Host Disease); By End User (Hospitals and Cancer Centers, Academic and Research Institutes, Specialty Clinics, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD5 Targeting Therapies Market valued at USD 1.8 billion in 2024 and forecast to reach USD 3.6 billion by 2030 at 10.4%, CAGR, led by targeted the... Read More

Published Date: DEC-2025 | No Of Pages:199 | $ 4485

Trigeminal Neuralgia Treatment Market By Treatment Type (Pharmacological Therapy, Surgical Procedures, Non-Invasive Therapies); By Drug Class (Anticonvulsants, Muscle Relaxants, Antidepressants, Others); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Trigeminal Neuralgia Treatment Market is valued at USD 675 million in 2024 and projected to reach USD 1.02 billion by 2030, expanding at a 7.1% CAGR, driv... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

DLL3 Targeted Therapies Market By Therapy Type (Antibody-Drug Conjugates, Bispecific Antibodies, Small Molecules, Cell Therapies); By Indication (Small Cell Lung Cancer, Large Cell Neuroendocrine Carcinoma, Other DLL3-Positive Tumors); By Route of Administration (Intravenous, Subcutaneous); By End User (Hospitals, Cancer Specialty Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global DLL3 Targeted Therapies Market is valued at USD 472.5 million in 2024 and projected to reach USD 1.34 billion by 2030, growing at a robust 18.9% CAGR, dri... Read More

Published Date: DEC-2025 | No Of Pages:168 | $ 4485